Annual Drug Patent Expirations for NOURIANZ
Nourianz is a drug marketed by Kyowa Kirin and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has sixty-one patent family members in eighteen countries.
The generic ingredient in NOURIANZ is istradefylline. One supplier is listed for this compound. Additional details are available on the istradefylline profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent expiration for Kyowa Kirin drug NOURIANZ